Eton Pharmaceuticals (ETON) Cash & Current Investments: 2019-2025
Historic Cash & Current Investments for Eton Pharmaceuticals (ETON) over the last 7 years, with Sep 2025 value amounting to $37.1 million.
- Eton Pharmaceuticals' Cash & Current Investments rose 83.21% to $37.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $94.9 million, marking a year-over-year increase of 24.81%. This contributed to the annual value of $14.9 million for FY2024, which is 30.17% down from last year.
- Eton Pharmaceuticals' Cash & Current Investments amounted to $37.1 million in Q3 2025, which was up 46.27% from $25.4 million recorded in Q2 2025.
- In the past 5 years, Eton Pharmaceuticals' Cash & Current Investments ranged from a high of $37.1 million in Q3 2025 and a low of $13.4 million during Q3 2022.
- In the last 3 years, Eton Pharmaceuticals' Cash & Current Investments had a median value of $20.3 million in 2024 and averaged $20.8 million.
- In the last 5 years, Eton Pharmaceuticals' Cash & Current Investments skyrocketed by 209.72% in 2021 and then tumbled by 41.09% in 2022.
- Quarterly analysis of 5 years shows Eton Pharmaceuticals' Cash & Current Investments stood at $14.4 million in 2021, then climbed by 13.18% to $16.3 million in 2022, then spiked by 31.17% to $21.4 million in 2023, then tumbled by 30.17% to $14.9 million in 2024, then spiked by 83.21% to $37.1 million in 2025.
- Its last three reported values are $37.1 million in Q3 2025, $25.4 million for Q2 2025, and $17.4 million during Q1 2025.